Paris, France

Pierre Fons


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 18(Granted Patents)


Location History:

  • Paris, FR (2015 - 2016)
  • Toulouse, FR (2016)

Company Filing History:


Years Active: 2015-2016

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Pierre Fons: Innovator in Therapeutic Solutions from Paris

Introduction

Pierre Fons, a notable inventor based in Paris, France, has made significant contributions to the field of biotechnology through his innovative patents. With an impressive portfolio of four patents, Fons is recognized for his groundbreaking work that targets specific therapeutic applications.

Latest Patents

Among his latest inventions is the technology surrounding FGF receptor-activating N-sulfate oligosaccharides. This invention describes oligosaccharides that can activate the FGF receptor and details their preparation and therapeutic applications. It presents a complex formula with various groups including hydroxyl and -O-alkyl components, underscoring the intricate nature of his research.

Another notable patent by Fons is the Robo1-Fc fusion protein. This recombinant protein has shown promise in treating tumors associated with the overexpression of Slit proteins, particularly in cancer scenarios. Moreover, this invention also proposes the use of the Robo1-Fc molecule as a diagnostic tool, facilitating the detection of specific overexpressed molecules within patients.

Career Highlights

Pierre Fons has established a substantial career at Sanofi, a leading global biopharmaceutical company. His work at Sanofi has positioned him at the forefront of medical innovation, particularly in developing therapeutic solutions that target complex diseases.

Collaborations

Throughout his career, Fons has collaborated with esteemed colleagues, including Philippe Duchaussoy and Francis Blanche. These collaborations have enriched his work, fostering an environment of shared knowledge and innovation that has been instrumental in advancing his projects and patents.

Conclusion

In conclusion, Pierre Fons exemplifies the essence of innovation in biotechnology and therapeutic development. His patents reflect a commitment to addressing pressing medical challenges, and his role at Sanofi highlights his impact on the industry. As the field evolves, Fons’ contributions will continue to inspire future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…